Results 171 to 180 of about 768,011 (297)

Letter re: Fort Worth Club office space

, 1924
Letter from F. E. Clarity, vice president and general manager of the Fort Worth and Denver City Railway company, to Amon Carter regarding office space at the Fort Worth ...
Clarity, Frank E.
core  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Association between patient-physician relationship and overall survival among African Americans with lung cancer: the Detroit Research on Cancer Survivors study. [PDF]

J Thorac Dis
Viana SW, Pratt CG, Mendy A, Griffith A, Pinney SM, Kovacic MB, Kues J, Ruterbusch JJ, Schwartz AG, Van Haren RM.   +9 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Multivariate analysis of metabolomic data to identify biological pathways modified by a clinical intervention. [PDF]

Metabolomics
Wood RM, Corbin LJ, Blazeby JM, Rogers CA, Timpson NJ, Lawson DJ.   +5 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Visual Performance of Two Daily Disposable Multifocal Contact Lenses in Presbyopic Soft Lens Wearers. [PDF]

Clin Ophthalmol
Stahl U, Woods J, Ng A, Luensmann D, Jones L.   +4 more
europepmc   +1 more source

Professional clarity

British Dental Journal
Feng, Y., Liu, C., Hao, Y., Gu, H.
openaire   +3 more sources

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

Molecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens, Anouk Mentink, Tom Niessink, Frank Coumans, Leonie Mekenkamp, Ruchi Bansal, Jeroen Hiltermann   +6 more
wiley   +1 more source

Latent profiles of moral sensitivity and its associated factors among operating room nurses. [PDF]

Front Med (Lausanne)
Chen XY, Yan F, Liu Y, He LJ, Xue CL, Gong RH.   +5 more
europepmc   +1 more source